AKT1 and hepatocellular carcinoma: A recent report suggested that knockdown of PI3K/AKT/mTOR suppressed the proliferation and migration of HCC cells [118], which demonstrated that inhibition of PI3K/AKT could be an effective molecular target for HCC therapy.